Suchergebnisse - "Khanna, Puja P"

PubPharm (10)

1

Sensitivity to change of the modified Rodnan skin score in diffuse systemic sclerosis--assessment of individual body sites in two large randomized controlled trials

enthalten in: Rheumatology (Oxford, England) | 2009

von Kaldas, M. | Khanna, P. | Furst, D. | +6

2

Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials : analysis of three large multicenter, double-blind, randomized controlled trials

enthalten in: Arthritis and rheumatism | 2009

von Amjadi, S. | Maranian, P. | Furst, D. | +6

3

Validating and assessing the sensitivity of the Health Assessment Questionnaire-Disability Index-derived Short Form-6D in patients with early aggressive rheumatoid arthritis

enthalten in: The Journal of rheumatology | 2009

von Amjadi, S. | Maranian, P. | Paulus, H. | +49

CommentIn: J Rheumatol. 2009 Jun;36(6):1093-5. - PMID 19509084

4

Validating and Assessing the Sensitivity of the Health Assessment Questionnaire-Disability Index-derived Short Form-6D in Patients with Early Aggressive Rheumatoid Arthritis

enthalten in: Journal of rheumatology | 2009

von Amjadi, S. | Maranian, P. | Paulus, H. | +5

5

Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: Analysis of three large multicenter, double-blind, randomized controlled trials

enthalten in: Arthritis & rheumatism | 2009

von Amjadi, S. | Maranian, P. | Furst, D. | +5

6

The minimally important difference for the fatigue visual analog scale in patients with rheumatoid arthritis followed in an academic clinical practice

enthalten in: The Journal of rheumatology | 2008

von Khanna, D. | Pope, J. | Khanna, P. | +5

7

COX-2 controversy: where are we and where do we go from here?

enthalten in: Inflammopharmacology | 2005

von Khanna, D. | Khanna, P. | Furst, D.

8

COX-2 controversy: where are we and where do we go from here?

enthalten in: Inflammopharmacology | 2005

von Khanna, D. | Khanna, P. | Furst, D.

9

COX-2 controversy: where are we and where do we go from here?

enthalten in: Inflammopharmacology | 2005

von Khanna, D. | Khanna, P. | Furst, D.

10

COX-2 controversy : where are we and where do we go from here?

enthalten in: Inflammopharmacology | 2005

von Khanna, D. | Khanna, P. | Furst, D.

1
[1]